Dipeptidyl peptidase

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (12:08, 30 December 2019) (edit) (undo)
 
(23 intermediate revisions not shown.)
Line 1: Line 1:
-
 
+
<StructureSection load='' size='350' side='right' caption='Human glycosylated dipeptidyl peptidase I complex with inhibitor, glycerol and chloride ion (green) (PDB entry [[4cdc]])' scene='43/433126/Cv/3'>
-
 
+
__TOC__
-
<StructureSection load='1jqp' size='350' side='right' caption='Glycosylated dipeptidyl peptidase complex with sulfate and chloride ion (green) (PDB entry [[1jqp]])' scene='Dipeptidyl_peptidase/Cv/1'>
+
== Function ==
[[Dipeptidyl peptidase]] (DPP) is an enzyme which cleaves dipeptides from polypeptides.<br />
[[Dipeptidyl peptidase]] (DPP) is an enzyme which cleaves dipeptides from polypeptides.<br />
-
* '''DPP-I''' is involved in inflammatory diseases.<br />
+
* '''DPP-I''' see [[Cathepsin]] C is involved in inflammatory diseases.<br />
* '''DPP-II''' is a serine protease.<br />
* '''DPP-II''' is a serine protease.<br />
* '''DPP-III''' acts similarly to DPP-IV.<br />
* '''DPP-III''' acts similarly to DPP-IV.<br />
-
* '''DPP-IV''' (or '''CD26''') cleaves proline dipeptides from the N-termini and is associated with immune regulation. For details see: [[Dipeptidyl peptidase IV]] and [[Dipeptidyl Peptidase-4 Inhibitor Pharmacokinetics]].
+
* '''DPP-IV''' (or '''CD26''') cleaves proline dipeptides from the N-termini and is associated with immune regulation.
 +
For details see:
 +
*[[Dipeptidyl peptidase IV]]
 +
*[[Saxagliptin]]
 +
*[[Sitagliptin]]
 +
*[[Vildagliptin]]
 +
*[[Treatments:Dipeptidyl Peptidase-4 Inhibitor Pharmacokinetics]]
 +
*[[Dipeptidyl Peptidase-4 Inhibitor Pharmacokinetics]].
 +
 
 +
* '''DPP-XI''' from ''Porphyromonas gingivalis'' cleaves preferentially substrates with Asp/Glu at the P1 position<ref>PMID:26057589</ref>.<br />
== Relevance ==
== Relevance ==
-
</StructureSection>
 
-
== 3D Structures of Dipeptidyl peptidase ==
 
-
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
+
DPP-IV level is alternating in certain malignancies.<ref>PMID:15375776</ref> DPP-IV inhibitors control body glucose levels and provide potential advantages in diabetes type 2 therapies.<ref>PMID:17073841</ref>
-
{{#tree:id=OrganizedByTopic|openlevels=0|
+
-
*DPP-I
+
== Disease ==
-
**[[1jqp]] – rDPP-I – rat<br />
+
DPP-IV is involved in the development of various chronic liver disease like hepatitis C virus infection.<ref>PMID:23613622</ref>
-
**[[1k3b]], [[2djg]] - hDPP-I – human<br />
+
-
**[[3pdf]], [[2djf]], [[4cdc]], [[4cdd]], [[4cde]], [[4cdf]] – hDPP-I + inhibitor
+
-
*DPP-II
+
== Structural highlights ==
-
**[[3n0t]] – hDPP-II peptidase domain residues 28-492+inhibitor<br />
+
Human DPP-I contains 3 chains. <scene name='43/433126/Cv/10'>Light</scene> and <scene name='43/433126/Cv/12'>heavy chains forming the catalytic site</scene> and a <scene name='43/433126/Cv/13'>third chain including the exclusion domain</scene> which is responsible of the exopeptidase activity of DPP-I by partially blocking the active site cleft. The <scene name='43/433126/Cv/14'>inhibitors binds to a Cys residue at the active site</scene>. <ref>PMID:24592859</ref>
-
**[[3jyh]], [[4ebb]] – hDPP-II peptidase domain residues 28-492<br />
+
-
*DPP-III
+
== 3D Structures of Dipeptidyl peptidase ==
 +
[[Dipeptidyl peptidase 3D structures]]
-
**[[3fvy]] – hDPP-III<br />
+
</StructureSection>
-
**[[3t6b]], [[3t6j]] - hDPP-III (mutant) + tynorphin<br />
+
-
**[[3csk]] – DPP-III (mutant) – yeast<br />
+
-
 
+
-
*DPP-IV (CD26)
+
-
 
+
-
**[[2onc]], [[1tk3]], [[1r9m]], [[1j2e]], [[1nu6]], [[1pfq]] – hDPP-IV extracellular domain<br />
+
-
**[[1u8e]] – hDPP-IV extracellular domain (mutant)<br />
+
-
**[[3kwj]], [[3oc0]], [[3kwf]], [[3q8w]] – hDPP-IV extracellular domain +quinoline derivative<br />
+
-
**[[3g0b]], [[3g0d]], [[3g0g]], [[3nox]], [[3hab]], [[3hac]], [[3f8s]], [[3h0c]], [[3ccb]], [[3ccc]], [[2qjr]], [[2qky]], [[3d4l]], [[2jid]], [[3bjm]], [[2rip]], [[2ole]], [[2rgu]], [[2i78]], [[2oag]], [[2oqv]], [[2oqi]], [[2ogz]], [[2i03]], [[2g5p]], [[2g5t]], [[2g63]], [[2bub]], [[2ajl]], [[1wcy]], [[1rwq]], [[1tkr]], [[1n1m]], [[3eio]], [[3g0c]], [[3opm]], [[3sww]], [[3sx4]], [[3q0t]], [[4a5s]], [[3vjk]], [[3vjl]], [[3vjm]], [[3w2t]], [[4dsa]], [[4dsz]], [[4dtc]], [[4g1f]],[[3o95]], [[3o9v]], [[4j3j]], [[4jh0]], [[4lko]], [[4n8d]], [[4n8e]], [[4pnz]], [[4pv7]] – hDPP-IV extracellular domain+inhibitor<br />
+
-
**[[1r9n]], [[2bgr]], [[1nu8]] – hDPP-IV extracellular domain+polypeptide<br />
+
-
**[[1w1i]] – hDPP-IV extracellular domain+adenosine deaminase<br />
+
-
**[[2bgn]] – hDPP-IV extracellular domain+adenosine deaminase+polypeptide<br />
+
-
**[[3c43]], [[3c45]], [[2qoe]], [[2qt9]], [[2qtb]], [[2p8s]], [[2oph]], [[2fjp]], [[1x70]], [[2iit]], [[2iiv]], [[3qbj]] – hDPP-IV extracellular domain (mutant) + inhibitor <br />
+
-
**[[4kr0]], [[4qzv]] - hDPP-IV extracellular domain + S protein<br />
+
-
**[[4l72]] – rDPP-IV + Mers-Cov Rbd<br />
+
-
**[[2gbc]] – rDPP-IV extracellular domain<br />
+
-
**[[2oae]], [[2i3z]], [[2gbf]], [[2gbg]], [[2gbi]] – rDPP-IV extracellular domain+inhibitor<br />
+
-
**[[4ffv]], [[4ffw]] – rDPP-IV + antibody<br />
+
-
**[[2aj8]], [[2ajb]], [[2ajc]], [[2ajd]], [[2bua]], [[2buc]], [[1orw]] – pDPP-IV extracellular domain+inhibitor - pig<br />
+
-
**[[1orv]] - pDPP-IV extracellular domain<br />
+
-
**[[2ecf]] - DPP-IV – ''Stenotrophomonas maltophilia''
+
-
 
+
-
*DPP-VI
+
-
 
+
-
**[[3pvq]], [[4r0k]] – DPP-VI – ''Bacterioides thetaiotamicron''
+
-
 
+
-
*DPP-X
+
-
 
+
-
**[[4wjl]] – hDPP-X extracellular domain<br />
+
-
}}
 
== References ==
== References ==
<references/>
<references/>
[[Category:Topic Page]]
[[Category:Topic Page]]

Current revision

Human glycosylated dipeptidyl peptidase I complex with inhibitor, glycerol and chloride ion (green) (PDB entry 4cdc)

Drag the structure with the mouse to rotate

References

  1. ↑ Sakamoto Y, Suzuki Y, Iizuka I, Tateoka C, Roppongi S, Fujimoto M, Inaka K, Tanaka H, Yamada M, Ohta K, Gouda H, Nonaka T, Ogasawara W, Tanaka N. Structural and mutational analyses of dipeptidyl peptidase 11 from Porphyromonas gingivalis reveal the molecular basis for strict substrate specificity. Sci Rep. 2015 Jun 9;5:11151. doi: 10.1038/srep11151. PMID:26057589 doi:http://dx.doi.org/10.1038/srep11151
  2. ↑ Pro B, Dang NH. CD26/dipeptidyl peptidase IV and its role in cancer. Histol Histopathol. 2004 Oct;19(4):1345-51. PMID:15375776
  3. ↑ Barnett A. DPP-4 inhibitors and their potential role in the management of type 2 diabetes. Int J Clin Pract. 2006 Nov;60(11):1454-70. PMID:17073841 doi:10.1111/j.1742-1241.2006.01178.x
  4. ↑ Itou M, Kawaguchi T, Taniguchi E, Sata M. Dipeptidyl peptidase-4: a key player in chronic liver disease. World J Gastroenterol. 2013 Apr 21;19(15):2298-306. doi:, 10.3748/wjg.v19.i15.2298. PMID:23613622 doi:http://dx.doi.org/10.3748/wjg.v19.i15.2298
  5. ↑ Furber M, Tiden AK, Gardiner P, Mete A, Ford R, Millichip I, Stein L, Mather A, Kinchin E, Luckhurst C, Barber S, Cage P, Sanganee H, Austin R, Chohan K, Beri R, Thong B, Wallace A, Oreffo V, Hutchinson R, Harper S, Debreczeni J, Breed J, Wissler L, Edman K. Cathepsin C Inhibitors: Property Optimization and Identification of a Clinical Candidate. J Med Chem. 2014 Mar 14. PMID:24592859 doi:http://dx.doi.org/10.1021/jm401705g

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky, Joel L. Sussman

Retrieved from "http://52.214.119.220/wiki/index.php/Dipeptidyl_peptidase"
Personal tools